SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
56 hedge funds and large institutions have $124M invested in Sorrento Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
+18
Holders Change %
+47.37%
% of All Funds
1.49%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
21
Increased
17
Reduced
13
Closed
3
Calls
$1.41M
Puts
$2.14M
Net Calls
-$726K
Net Calls Change
-$726K
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$15.1M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$5.74M |
| 3 |
Millennium Management
New York
|
+$5.13M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.8M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.76M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$12.8M |
| 2 |
TC
Talkot Capital
Sausalito,
California
|
-$2.76M |
| 3 |
SCM
Sio Capital Management
New York
|
-$1.86M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.12M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$824K |
